STK11 and neoplasm: Given our findings that STK11 knockout (KO) decreases EOC spheroid cell viability [14] and tumor burden in mice [26], we proposed that disrupting spheroid formation by downregulating LKB1 and STRAD would impair the metastatic properties of human EOC cells.